What is G Medical Innovations Holdings Ltd (GMVD) stock price today?

G Medical Innovations Holdings Ltd (GMVD) is currently trading at $0.18, up 1.38% today.

What is GMVD P/E ratio?

G Medical Innovations Holdings Ltd's P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is GMVD return on equity (ROE)?

G Medical Innovations Holdings Ltd's return on equity (ROE) is 208.58%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is G Medical Innovations Holdings Ltd's market cap?

G Medical Innovations Holdings Ltd has a market capitalization of $1.80M.

NASDAQ · Medical - Instruments & Supplies

G Medical Innovations Holdings Ltd (GMVD) Stock

$0.18 +1.38% NASDAQ: GMVD Healthcare

Valuation

Metric	Value
Price	$0.18
Market Cap	$1.80M
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.41
EPS (TTM)	$0.00
52-Week High	$13.83
52-Week Low	$0.14
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	208.58%
ROA	-289.28%
ROCE	639.23%
Gross Margin	17.74%
Operating Margin	-620.14%
Net Margin	-315.79%
Debt/Equity	-0.28
Current Ratio	0.22

Annual Financials (USD)

Metric	2018	2019	2020	2021	2022
Revenue	$2.0M	$4.0M	$5.0M	$5.0M	$4.0M
Operating Profit	$-13.0M	$-10.0M	$-12.0M	$-11.0M	$-27.0M
Net Profit	$-13.0M	$-11.0M	$-13.0M	$-15.0M	$-14.0M
EPS	$-6.65	$-4.92	$-60.40	$-45.89	$0.00
Op Margin	-533.2%	-262.9%	-245.0%	-222.8%	-620.1%

Balance Sheet (USD)

Metric	2018	2019	2020	2021	2022
Total Assets	$11.0M	$6.0M	$5.0M	$11.0M	$5.0M
Total Liabilities	$13.0M	$13.0M	$8.0M	$13.0M	$9.0M
Cash	$2.0M	$1.0M	$0	$6.0M	$0
Borrowings	$9.0M	$7.0M	$3.0M	$8.0M	$2.0M

Cash Flow (USD)

Metric	2018	2019	2020	2021	2022
Operating Cash Flow	$-12.0M	$0	$-5.0M	$-11.0M	$-18.0M
Investing Cash Flow	$-6.0M	$-1.0M	$-1.0M	$-1.0M	$-4.0M
Financing Cash Flow	$7.0M	$3.0M	$5.0M	$17.0M	$15.0M
Net Cash Flow	$-9.0M	$3.0M	$0	$6.0M	$-6.0M
Free Cash Flow	$-14.0M	$0	$-5.0M	$-12.0M	$-21.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.12
FCF Yield	-1143.71%
Quick Ratio	0.19
Interest Coverage	0.00
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ASLNASLAN Pharmaceuticals Limited	$0.60	-14.27%	-0.06	$777.12M	0.00%
AVGRAvinger, Inc.	$0.47	-20.74%	-0.02	$1.52M	0.00%
BACKIMAC Holdings, Inc.	$0.02	+0.00%	-0.01	$79484	0.00%
CMAXCareMax, Inc.	$0.42	+100.00%	0.00	$1.61M	0.00%
CUTRCutera, Inc.	$0.10	+0.00%	-0.01	$1.96M	0.00%

About G Medical Innovations Holdings Ltd

G Medical Innovations Holdings Ltd, along with its affiliated companies, operates as an early-stage commercial healthcare enterprise. It specializes in creating advanced mobile health and remote medical solutions for markets in the United States, China, and Israel. The company's product portfolio features Prizma, a user-friendly medical device that records vital signs, integrates with electronic medical records, and generates reports adhering to clinical standards. Another key offering is the Extended Holter Patch System, a multi-channel wearable biosensor designed for continuous electrocardiogram data collection for up to two weeks. Furthermore, it is developing a Wireless Vital Signs Monitoring System, intended for real-time and ongoing tracking of physiological parameters and biometrics. Beyond its devices, G Medical Innovations provides monitoring services, encompassing both independent diagnostic testing facility oversight and private patient monitoring. The company was established in 2014 and maintains its headquarters in Rehovot, Israel.

G Medical Innovations Holdings Ltd is headquartered in IL.

G Medical Innovations Holdings Ltd (GMVD) stock trades at $0.18 with a market capitalization of $1.80M. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.41. Over the past 52 weeks the stock has ranged between $0.14 and $13.83, and currently trades 98.7% below its 52-week high.

On profitability, G Medical Innovations Holdings Ltd generates a return on equity (ROE) of 208.58% — well above the market average, a sign of a high-quality business, return on capital employed of 639.23%, an operating margin of -620.14%, a net profit margin of -315.79%.

Official website: gmedinnovations.com